270 related articles for article (PubMed ID: 23597495)
1. Radiofrequency ablation for liver metastasis from gastric cancer.
Chen J; Tang Z; Dong X; Gao S; Fang H; Wu D; Xiang D; Zhang S
Eur J Surg Oncol; 2013 Jul; 39(7):701-6. PubMed ID: 23597495
[TBL] [Abstract][Full Text] [Related]
2. Hepatic resection for synchronous hepatic metastasis from gastric cancer.
Qiu JL; Deng MG; Li W; Zou RH; Li BK; Zheng Y; Lao XM; Zhou K; Yuan YF
Eur J Surg Oncol; 2013 Jul; 39(7):694-700. PubMed ID: 23579173
[TBL] [Abstract][Full Text] [Related]
3. Resection of liver metastases in patients with breast cancer: survival and prognostic factors.
van Walsum GA; de Ridder JA; Verhoef C; Bosscha K; van Gulik TM; Hesselink EJ; Ruers TJ; van den Tol MP; Nagtegaal ID; Brouwers M; van Hillegersberg R; Porte RJ; Rijken AM; Strobbe LJ; de Wilt JH;
Eur J Surg Oncol; 2012 Oct; 38(10):910-7. PubMed ID: 22682709
[TBL] [Abstract][Full Text] [Related]
4. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
5. Solitary colorectal liver metastasis: resection determines outcome.
Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation for metachronous hepatic metastases from gastric cancer.
Kim HO; Hwang SI; Hong HP; Yoo CH
Surg Laparosc Endosc Percutan Tech; 2009 Jun; 19(3):208-12. PubMed ID: 19542847
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis.
Lee WS; Yun SH; Chun HK; Lee WY; Kim SJ; Choi SH; Heo JS; Joh JW; Choi D; Kim SH; Rhim H; Lim HK
J Clin Gastroenterol; 2008 Sep; 42(8):945-9. PubMed ID: 18438208
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
11. Outcome after simultaneous resection of gastric primary tumour and synchronous liver metastases: survival analysis of a single-center experience in China.
Liu Q; Bi JJ; Tian YT; Feng Q; Zheng ZX; Wang Z
Asian Pac J Cancer Prev; 2015; 16(4):1665-9. PubMed ID: 25743789
[TBL] [Abstract][Full Text] [Related]
12. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
Gleisner AL; Choti MA; Assumpcao L; Nathan H; Schulick RD; Pawlik TM
Arch Surg; 2008 Dec; 143(12):1204-12. PubMed ID: 19075173
[TBL] [Abstract][Full Text] [Related]
13. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
14. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
Cheung TT; Ng KK; Poon RT; Fan ST
J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections.
Takemura N; Saiura A; Koga R; Arita J; Yoshioka R; Ono Y; Hiki N; Sano T; Yamamoto J; Kokudo N; Yamaguchi T
Langenbecks Arch Surg; 2012 Aug; 397(6):951-7. PubMed ID: 22615045
[TBL] [Abstract][Full Text] [Related]
16. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.
Facciorusso A; Del Prete V; Antonino M; Crucinio N; Neve V; Di Leo A; Carr BI; Barone M
Dig Liver Dis; 2014 Nov; 46(11):1014-9. PubMed ID: 25085684
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma.
Kim HR; Cheon SH; Lee KH; Ahn JR; Jeung HC; Lee SS; Chung HC; Noh SH; Rha SY
Int J Hyperthermia; 2010; 26(4):305-15. PubMed ID: 20210605
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.
Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M
Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases.
Leblanc F; Fonck M; Brunet R; Becouarn Y; Mathoulin-Pélissier S; Evrard S
Eur J Surg Oncol; 2008 Feb; 34(2):185-90. PubMed ID: 17998155
[TBL] [Abstract][Full Text] [Related]
20. Prognosis and surgical treatment of gastric cancer invading adjacent organs.
Zhang M; Zhang H; Ma Y; Zhu G; Xue Y
ANZ J Surg; 2010; 80(7-8):510-4. PubMed ID: 20795964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
